跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
施达赛 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Dasatinib Tablets
Approved
化学药品
Dasatinib Tablets
Bristol-Myers Squibb Pharma EEIG
🇨🇳 National Medical Products Administration
Approval Date
Sep 25, 2020
Approval ID
888UkpU0jZk
Company
Bristol-Myers Squibb Pharma EEIG
Type
化学药品
Approval Details
Approval Id
888UkpU0jZk
Approval Number
国药准字HJ20160434
Generic Name
达沙替尼片
Generic Name En
Dasatinib Tablets
Trade Name
施达赛
Drug Type
化学药品
Dosage Form
片剂
Strength
70mg
Reg Date
2020-09-25
Expired Date
2025-09-24
Company Name
Bristol-Myers Squibb Pharma EEIG
Production Company Name
Patheon Inc
Company Detail Path
/organization/bristol-myers-squibb-pharma-eeig
Production Company Detail Path
/organization/patheon-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 25, 2020
Approval ID
888UkpU0jZk
Type
化学药品
Back to NMPA Approvals